John Colwell to Cardiovascular Diseases
This is a "connection" page, showing publications John Colwell has written about Cardiovascular Diseases.
Connection Strength
1.347
-
Does aspirin use reduce cardiovascular risk in diabetes? Nat Rev Endocrinol. 2009 Apr; 5(4):188-90.
Score: 0.188
-
Racial disparities in trends for cardiovascular disease and procedures among hospitalized diabetic patients. Ethn Dis. 2008; 18(2):131-5.
Score: 0.172
-
Aspirin for the primary prevention of cardiovascular events. Drugs Today (Barc). 2006 Jul; 42(7):467-79.
Score: 0.155
-
Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus. Am J Cardiovasc Drugs. 2004; 4(2):87-106.
Score: 0.130
-
Aspirin for primary prevention of cardiovascular events in diabetes. Diabetes Care. 2003 Dec; 26(12):3349-50.
Score: 0.130
-
Hemoglobin A1c is not the only issue. Curr Diab Rep. 2002 Aug; 2(4):295-6.
Score: 0.118
-
Multifactorial aspects of the treatment of the type II diabetic patient. Metabolism. 1997 Dec; 46(12 Suppl 1):1-4.
Score: 0.085
-
Aspirin therapy in diabetes. Diabetes Care. 1997 Nov; 20(11):1767-71.
Score: 0.085
-
Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus. Metabolism. 1992 May; 41(5 Suppl 1):7-10.
Score: 0.058
-
Aspirin for primary prevention of cardiovascular events in people with diabetes. J Am Coll Cardiol. 2010 Jun 22; 55(25):2878-86.
Score: 0.051
-
Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care. 2010 Jun; 33(6):1395-402.
Score: 0.051
-
Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Circulation. 2010 Jun 22; 121(24):2694-701.
Score: 0.051
-
The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care. 2003 Jul; 26(7):2181-8.
Score: 0.031
-
A critical issue. Intensive insulin treatment and macrovascular disease. Diabetes Care. 1998 Apr; 21(4):669-71.
Score: 0.022
-
Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med. 1997 Jan 27; 157(2):181-8.
Score: 0.020